The Clinical study of tandospirone combined with Agomelatine in treatment of senile depression after stroke
-
摘要:
目的 探讨坦度螺酮联合阿戈美拉汀治疗老年性卒中后抑郁的有效性及安全性。 方 法将61例老年性卒中后抑郁患者分为治疗组31例、对照组30例;治疗组给予坦度螺酮联合阿戈美拉汀治疗,对照组给予阿戈美拉汀治疗;分别在治疗第2、4周,用抑郁量表(HAMD)、焦虑量表(HAMA)及副作用量表(TESS)评定。 结果两组临床疗显效率有显著性差异(P<0.05)。副反应两组间无显著性差异(P>0.05)。 结论坦度螺酮联合阿戈美拉汀治疗老年性卒中后抑郁疗效显著,安全性高。 Abstract:ObjectiveTo investigate the effectiveness and safety of tandospirone combined with agomelatine treatment of Senile post- stroke depression. Methods 61 cases of patients with Senile post- stroke depression were divided into treatment group of 31 cases, 30 cases in the control group , The treatment group was given tandospirone combined with agomelatine treatment, The control group was given agomelatine treatment; In treatment 2, 4 weeks, depression scale (HAMD), anxiety scale (HAMA) and side effects scale (TESS) assessment. ResultsClinical treatment of the two group of significant efficiency had significant difference (P<0.05). Adverse reaction between two groups had no significant difference (P>0. 05). ConclusionsTandospirone combined with agomelatine treatment of senile post-stroke depression curative effect, high safety. -
表 1 两组抗抑郁临床疗效比较
组别 痊愈 显著进步 进步 无效 显效率 坦度螺酮联合阿戈美拉汀组 11 17 3 0 90.32 阿戈美拉汀组 8 16 6 0 80 表 2 两组HAMD评分比较
组别 例数 治疗前 治疗2周末 治疗4周末 坦度螺酮联合阿戈美拉汀组 31 25.71±4.09 14.20±3.52 7.61±3.22 阿戈美拉汀组 30 26.21±3.14 16.99±3.22 10.73±3.14 表 3 两组HAMA评分比较
组别 治疗1周末 治疗2周末 治疗4周末 坦度螺酮联合阿戈美拉汀组 2.89±3.19 3.59±4.53 3.21±3.22 阿戈美拉汀组 2.91±3.33 3.43±4.10 3.11±3.01 表 4 两组TESS评分比较
组别 例数 治疗前 治疗2周末 治疗4周末 坦度螺酮联合阿戈美拉汀组 31 21.33±5.22 12.21±4.13 7.34±3.11 阿戈美拉汀组 30 21.43±5.59 16.51±4.12 11.42±3.93 -
[1] Edge L. Tackling the global burden of stroke[J]. Lancet Neurol, 2005, 4(11): 689. doi: 10.1016/S1474-4422(05)70202-7 [2] Strik JM. Bogousslavsky JExpert Rev NeurotherPost[J]. Stroke lepreaion, 2008, 8(1): 45. [3] 李文华, 伍龙. 脑卒中后抑郁症发生率相关因素调查[J]. 广西医科大学学报, 2006, 23(1): 158-9. http://www.cnki.com.cn/Article/CJFDTOTAL-GXYD200601089.htm [4] 刘素坤, 赵秀敏. 卒中后抑郁发生率及针灸治疗[J]. 中国针灸, 2006, 26(7): 472-4. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE200607004.htm [5] 赵红, 王春毅. 初发脑卒中患者并发抑郁症相关因素分析[J]. 中国针灸, 2007, 27(1): 9-11. http://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE200701005.htm [6] Aben I, Verhey F, Strik J, et al. A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction[J]. J Neurol Neurosurg Psychiatry, 2003, 74(5): 581-5. doi: 10.1136/jnnp.74.5.581 [7] 许南燕, 江先娣. 脑卒中后抑郁状态的随访研究[J]. 现代康复, 2000, 4 (9): 1330-1. http://www.cnki.com.cn/Article/CJFDTOTAL-XDKF200009033.htm [8] Kauhanen M, Korpelainen JT, Hiltunen P, et al. Poststroke depression correlates with cognitive impairment and neurological deficits [J]. Stroke, 1999, 30(9): 1875-80. doi: 10.1161/01.STR.30.9.1875 [9] 付朝伟, 徐彪, 詹思延, 等. 中国四城市综合医院神经内科患者抑郁, 焦虑现况研究[J]. 中华流行病学杂志, 2006, 27(9): 803-7. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHLX200609023.htm [10] Astrom M, Adolfsson R. Major depression in stroke patients[J]. Stroke, 1993, 24(7): 976-82. doi: 10.1161/01.STR.24.7.976 [11] 永珍, 龙洁. 卒中后抑郁状态对预后的影响及治疗避[J]. 国外医学: 脑血管病分册, 2001, 9(4): 245-7. http://www.cnki.com.cn/Article/CJFDTOTAL-NXGF200104017.htm [12] Anon.全国第四届脑血管病学术会议各类脑血管病诊断要点及脑卒中患者临床神经功能缺损程度评分标准中华神经科杂志, 1996, 29 (6): 379. http://www.oalib.com/references/19720947 [13] 中华医学会精神科分会冲国精神障碍分类与诊断标准[M]3版. 济南: 山东科学技术出版社, 2001: 87. [14] 张明圆. 精神科评定量表手册[M]. 长沙: 湖南科学技术出版社, 1993. [15] Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders [J]. Brain, 1987, 110(Pt 4): 1045-59. http://cn.bing.com/academic/profile?id=62da134d3c7331f91f1126348df09999&encoded=0&v=paper_preview&mkt=zh-cn [16] 于欣, 许滨, 田运华, 等. 老年期情感障碍的临床特点及随访研究 [J]. 中国心理卫生杂志, 1997, 11(5): 276. http://www.cnki.com.cn/Article/CJFDTOTAL-ZXWS705.007.htm [17] 李根华. 脑卒中后抑郁症[J]. 凋外医学:脑血管疾病分册, 1996, 4: 22- 4.
计量
- 文章访问数: 636
- HTML全文浏览量: 288
- PDF下载量: 3
- 被引次数: 0